Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Infectious Disease

Why Test for Loa loa Before Treating Lymphatic Filariasis?

At a Glance

Testing for Loa loa and river blindness before treating lymphatic filariasis is a critical safety measure. Standard medications rapidly kill these parasites, and if you are co-infected, this sudden die-off can trigger life-threatening brain inflammation or severe full-body immune reactions.

Before you can safely take medication for lymphatic filariasis, your doctor must ensure you do not have certain other parasitic worms—most importantly Loa loa (African eye worm), as well as Onchocerca volvulus (the worm that causes river blindness). Taking standard filariasis medications while carrying a high number of these other worms can trigger sudden, severe, and potentially life-threatening reactions [1][2]. Testing you first is a critical, life-saving precaution [3][4].

Why Do These Medications Cause Reactions?

The primary medications used to treat lymphatic filariasis, such as diethylcarbamazine (DEC) and ivermectin, work by rapidly killing the microscopic baby worms (microfilariae) in your bloodstream.

If you are co-infected with Loa loa or Onchocerca, these drugs will attack and kill those microfilariae as well. The sudden death of massive numbers of these worms triggers an overwhelming inflammatory response from your immune system [5][6].

The Risk of Loa loa: Post-Treatment Encephalopathy

If a person has a high density of Loa loa microfilariae in their blood, taking DEC or ivermectin carries a severe risk of encephalopathy, which is life-threatening brain inflammation [1][7][8].

This complication occurs because the sudden death of huge numbers of worms can obstruct small blood vessels in the brain and provoke an intense immune reaction [5][9]. The risk of encephalopathy is directly tied to the “worm burden”—the higher the number of Loa loa microfilariae in the blood, the higher the danger [10][11]. This is why doctors must precisely measure the parasite levels in your blood before administering these medications [7][12].

The Risk of Onchocerciasis: The Mazzotti Reaction

If you have onchocerciasis (river blindness) and take DEC, the rapid die-off of worms can trigger what is known as the Mazzotti reaction [13][6].

This is an intense, full-body inflammatory response. Symptoms can include severe itching, fever, muscle pain, extreme fatigue, and dangerous ocular (eye) complications that can lead to permanent vision loss [2][14]. Because of this severe risk, DEC is strictly avoided if there is any chance you have onchocerciasis (though ivermectin is actually a standard treatment for it) [15][16].

What the Testing Process Involves

Knowing what to expect can make the waiting period feel more manageable. Testing for Loa loa typically involves a simple blood draw, often done during the middle of the day when these specific microfilariae are most active in the bloodstream [17][18]. Testing for onchocerciasis traditionally involves a painless “skin snip” (a tiny surface sample of skin) [19][20]. There are also newer, rapid blood tests that can check for both parasites [21][22]. Test results can take anywhere from a few days to a couple of weeks, depending on the laboratory.

Why the Delay is Necessary (and What to Do Now)

Waiting for test results before starting medication can be deeply frustrating when you are eager to treat the swelling and discomfort of lymphatic filariasis. However, standard clinical protocols use this “test-and-treat” strategy specifically to prevent dangerous complications [3][4].

If tests show you have high levels of Loa loa or onchocerciasis, your doctor will use alternative, safer strategies [23]. This might involve different medications or a modified schedule to gradually reduce the number of worms without putting your life or vision at risk [24][25].

While you wait for your results, talk to your medical team about managing your current symptoms. They may recommend gentle washing, elevating the affected limb, and skin care to help manage swelling and prevent bacterial infections until you can safely begin your parasite medication.

Common questions in this guide

What Are the Best Shoes & Creams for Elephantiasis?Can Medication Cure a Filarial Hydrocele?How to Manage Depression with Lymphatic FilariasisDoes Lymphatic Filariasis Medication Cure Swelling?How to Care for Swollen Legs with Lymphatic FilariasisHow Long Is Filarial Hydrocele Surgery Recovery?Is There Surgery for Lymphatic Filariasis Elephantiasis?Should You Use Compression During a Lymphedema Attack?What Are Lymphatic Filariasis Treatment Side Effects?What Causes Painful Red Swelling in Lymphatic Filariasis?What Doctors Treat Lymphatic Filariasis?What Is the Filarial Dance Sign on an Ultrasound?Why is Doxycycline Used to Treat Lymphatic Filariasis?Why Do I Need a Nighttime Blood Test for Filariasis?
Why do I need a blood test before starting medication for lymphatic filariasis?
Doctors must check if you have other parasitic worms like Loa loa or Onchocerca. Taking filariasis medication while having high numbers of these other worms can cause a massive die-off that triggers a sudden, dangerous immune reaction.
What is the risk of having Loa loa when treating lymphatic filariasis?
If you have a high number of Loa loa worms in your blood, standard filariasis medications kill them too rapidly. This massive die-off can obstruct small blood vessels in the brain and trigger a life-threatening inflammation known as encephalopathy.
What happens if my Loa loa test comes back positive?
If you test positive for high levels of Loa loa or river blindness, your doctor will avoid standard medications like DEC. Instead, they will create an alternative, safer treatment plan to gradually reduce the worms without putting your health at risk.
How will my doctor test me for Loa loa?
Testing typically involves a simple blood draw. It is often done during the middle of the day because that is when the microscopic Loa loa worms are most active and easily detected in the bloodstream.
What can I do to manage lymphatic filariasis swelling while waiting for my test results?
While waiting for test results, you can manage swelling by elevating the affected limb and practicing good skin care. Gentle washing helps prevent secondary bacterial infections until you can safely begin your parasite medication.

Questions for Your Doctor

4 questions

  • •Which specific tests are you running to check for Loa loa or Onchocerciasis, and when should we expect the results?
  • •If my tests come back positive for these other worms, what is the alternative treatment plan for my lymphatic filariasis?
  • •Are there any specific symptoms of an adverse reaction I should watch for once I do start my filariasis medication?
  • •What safe, non-medication strategies (like limb elevation or skin care) can I start using right now to manage my swelling while we wait?

Questions for You

4 questions

  • •Have I ever traveled to or lived in regions of Central or West Africa where Loa loa or Onchocerciasis are common?
  • •Have I experienced any unusual symptoms like temporary swellings on my arms or legs, or intense itching and skin changes?
  • •Have I noticed any changes in my vision or ever felt the sensation of something moving in my eye?
  • •Am I keeping track of my daily symptoms so I can report any changes to my care team while waiting for the test results?

References

References (25)
  1. 1

    Albendazole-related Loa Loa encephalopathy.

    Métais A, Michalak S, Rousseau A

    IDCases 2021; (23()):e01033 doi:10.1016/j.idcr.2020.e01033.

    PMID: 33489754
  2. 2

    Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.

    Fischer PU, King CL, Jacobson JA, Weil GJ

    PLoS neglected tropical diseases 2017; (11(1)):e0005163 doi:10.1371/journal.pntd.0005163.

    PMID: 28056015
  3. 3

    A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon.

    Lenk EJ, Moungui HC, Boussinesq M, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020; (70(8)):1628-1635 doi:10.1093/cid/ciz461.

    PMID: 31165855
  4. 4

    An Integrated District Mapping Strategy for Loiasis to Enable Safe Mass Treatment for Onchocerciasis in Gabon.

    Ella SN, Ogoussan K, Gass K, et al.

    The American journal of tropical medicine and hygiene 2021; (106(2)):732-739.

    PMID: 34781262
  5. 5

    Encephalopathy in a patient with loiasis treated with albendazole: A case report.

    Volpicelli L, De Angelis M, Morano A, et al.

    Parasitology international 2020; (75()):102006 doi:10.1016/j.parint.2019.102006.

    PMID: 31676328
  6. 6

    Evaluation of oxfendazole in the treatment of zoonotic Onchocerca lupi infection in dogs.

    Colella V, Maia C, Pereira A, et al.

    PLoS neglected tropical diseases 2018; (12(1)):e0006218 doi:10.1371/journal.pntd.0006218.

    PMID: 29377880
  7. 7

    Activity of antifilarial drugs on microfilaremia in the treatment of loiasis: a systematic review.

    Michelitsch P, Matthies L, Nordmann T, et al.

    Parasites & vectors 2025; doi:10.1186/s13071-025-07189-w.

    PMID: 41372923
  8. 8

    Central and Peripheral Nervous System Disorders Following Ivermectin Mass Administration: A Descriptive Study Based on the Democratic Republic of Congo Pharmacovigilance System.

    Nzolo D, Anto F, Hailemariam S, et al.

    Drugs - real world outcomes 2017; (4(3)):151-158 doi:10.1007/s40801-017-0110-0.

    PMID: 28600751
  9. 9

    Serious Neurological Adverse Events after Ivermectin-Do They Occur beyond the Indication of Onchocerciasis?

    Chandler RE

    The American journal of tropical medicine and hygiene 2018; (98(2)):382-388 doi:10.4269/ajtmh.17-0042.

    PMID: 29210346
  10. 10

    A novel antigen biomarker for detection of high-level of Loa loa microfilaremia.

    Greene SE, Huang Y, Fischer K, et al.

    PLoS neglected tropical diseases 2024; (18(9)):e0012461 doi:10.1371/journal.pntd.0012461.

    PMID: 39226306
  11. 11

    Effect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled Trial.

    Kamgno J, Nguipdop-Djomo P, Gounoue R, et al.

    PLoS neglected tropical diseases 2016; (10(3)):e0004492 doi:10.1371/journal.pntd.0004492.

    PMID: 26967331
  12. 12

    Clinical Features of Imported Loiasis: A Case Series from the Hospital for Tropical Diseases, London.

    Saito M, Armstrong M, Boadi S, et al.

    The American journal of tropical medicine and hygiene 2015; (93(3)):607-11 doi:10.4269/ajtmh.15-0214.

    PMID: 26101271
  13. 13

    Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.

    Awadzi K, Opoku NO, Attah SK, et al.

    Parasites & vectors 2015; (8()):515 doi:10.1186/s13071-015-1122-9.

    PMID: 26452723
  14. 14

    Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.

    Herrick JA, Legrand F, Gounoue R, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017; (64(8)):1017-1025 doi:10.1093/cid/cix016.

    PMID: 28329346
  15. 15

    Immunotherapy with mutated onchocystatin fails to enhance the efficacy of a sub-lethal oxytetracycline regimen against Onchocerca ochengi.

    Bah GS, Tanya VN, Makepeace BL

    Veterinary parasitology 2015; (212(1-2)):25-34.

    PMID: 26100152
  16. 16

    Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.

    Wanji S, Nji TM, Hamill L, et al.

    Parasites & vectors 2019; (12(1)):574 doi:10.1186/s13071-019-3826-8.

    PMID: 31801631
  17. 17

    Loiasis and diurnal microfilaremia: searching at the right moment.

    Musumeci S, Ramu L, Chappuis F, Eperon G

    Journal of travel medicine 2022; (29(1)) doi:10.1093/jtm/taab176.

    PMID: 34718684
  18. 18

    Performance of Field's Stain Compared with Conventional Giemsa Stain for the Rapid Detection of Blood Microfilariae in Gabon.

    Ekoka Mbassi FA, Mombo-Ngoma G, Ndoumba WN, et al.

    The American journal of tropical medicine and hygiene 2022; (107(2)):383-387 doi:10.4269/ajtmh.22-0061.

    PMID: 35895407
  19. 19

    Loa loa Microfilariae in Skin Snips: Consequences for Onchocerciasis Monitoring and Evaluation in L. loa-Endemic Areas.

    Nana-Djeunga HC, Fossuo-Thotchum F, Pion SD, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019; (69(9)):1628-1630 doi:10.1093/cid/ciz172.

    PMID: 30861060
  20. 20

    Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas.

    Niamsi-Emalio Y, Nana-Djeunga HC, Chesnais CB, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021; (72(Suppl 3)):S158-S164 doi:10.1093/cid/ciab255.

    PMID: 33909066
  21. 21

    Performance of two serodiagnostic tests for loiasis in a Non-Endemic area.

    Gobbi F, Buonfrate D, Boussinesq M, et al.

    PLoS neglected tropical diseases 2020; (14(5)):e0008187 doi:10.1371/journal.pntd.0008187.

    PMID: 32453734
  22. 22

    Colorimetric and Real-Time Loop-Mediated Isothermal Amplification (LAMP) for Detection of Loa loa DNA in Human Blood Samples.

    Febrer-Sendra B, Fernández-Soto P, Crego-Vicente B, et al.

    Diagnostics (Basel, Switzerland) 2022; (12(5)) doi:10.3390/diagnostics12051079.

    PMID: 35626235
  23. 23

    Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo.

    Pion SDS, Chesnais CB, Weil GJ, et al.

    The Lancet. Infectious diseases 2017; (17(7)):763-769 doi:10.1016/S1473-3099(17)30175-5.

    PMID: 28372977
  24. 24

    Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.

    Cano J, Basáñez MG, O'Hanlon SJ, et al.

    Parasites & vectors 2018; (11(1)):70 doi:10.1186/s13071-018-2655-5.

    PMID: 29382363
  25. 25

    Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial.

    Chesnais CB, Hemilembolo MC, Sahm BA, et al.

    Nature communications 2025; (16(1)):6191 doi:10.1038/s41467-025-61479-6.

    PMID: 40615414

This page is for informational purposes only and explains the clinical importance of testing prior to lymphatic filariasis treatment. Always consult your infectious disease specialist before starting or changing any parasite medications.

Get notified when new evidence is published on Lymphatic filariasis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.